Daniel Goodman

A synthetic immunologist and computational biologist working at the intersection of genome engineering, immune cell therapy, and genetic design using generative models. Working at UCSF with Kole Roybal & Alex Marson on the next generation of T cell therapies for cancer and autoimmune disease. MIT Ph. D. alum from George Church's lab.